Mazā asinsrites loka saslimšanas

Humbert M et al: 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 43(38):3618-731, 2022 Simonneau G et al: Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 53(1):1801913, 2019

Hoeper MM et al: COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Eur Respir J. 60(1):2102311, 2022

Frost A et al: Diagnosis of pulmonary hypertension. Eur Respir J. 53(1):1801904, 2019

Klinger JR et al: Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report. Chest. 155(3):565-86, 2019

Morrell NW et al: Genetics and genomics of pulmonary arterial hypertension. Eur Respir J. 53(1):1801899, 2019

Sharma M et al: Revisiting a distinct entity in pulmonary vascular disease: chronic thromboembolic pulmonary hypertension (CTEPH). Medicina (Kaunas). 57(4):355, 2021

Konstantinides SV et al: 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 41(4):543-603, 2020

Moore C et al: Challenges and changes to the management of pulmonary embolism in the emergency department. Clin Chest Med. 39(3):539-47, 2018

Stevens SM et al: Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. ePub, 2021

Sanz J., et al.: Anatomy, function, and dysfunction of the right ventricle . J Am Coll Cardiol 2019; 3 (12): pp. 1463-1482.

Repessé X., et al.: Acute cor pulmonale in ARDS: rationale for protecting the right ventricle . Chest 2015; 147 (1): pp. 259-265

Ghofrani H.A., et al.: Acute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary disease . Pulm Circ 2015; 5 (2): pp. 296-304